FDA.reportPublic FDA data

PACLITAXEL

Substance profile for UNII P88XT4IS4D, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PACLITAXEL
Structure render from PubChem CID 36314

Substance Identity#

UNII
P88XT4IS4D
Preferred term
PACLITAXEL
Registry number
33069-62-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C47H51NO14
Chemical structure for PACLITAXEL
Structure render from PubChem CID 36314

Chemical And Database Identifiers#

InChIKey
RCINICONZNJXQF-MZXODVADSA-N
SMILES
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7
RxCUI
56946
PubChem
36314
NCIt
C1411
INN ID
7052

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound36314pubchem.ncbi.nlm.nih.gov/compound/36314
PubChem InChIKey SearchRCINICONZNJXQF-MZXODVADSA-Npubchem.ncbi.nlm.nih.gov/#query=RCINICONZNJXQF-MZXODVADSA-N
RxNorm56946mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=56946
NCI ThesaurusC1411ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1411
FDA Substance Registration SystemP88XT4IS4Dprecision.fda.gov/uniisearch/srs/unii/P88XT4IS4D

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTABRAXANE (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [ABRAXIS BIOSCIENCE, LLC]24
ACTIVE MOIETYABRAXANE (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [ABRAXIS BIOSCIENCE, LLC]24
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]18
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]18
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [SANDOZ INC]9
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [SANDOZ INC]9
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]7
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]7
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [ACTAVIS PHARMA, INC.]6
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [ACTAVIS PHARMA, INC.]6
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]6
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]6
ACTIVE INGREDIENTPACCAL VET-CA1 (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBOTT LABORATORIES]5
ACTIVE MOIETYPACCAL VET-CA1 (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBOTT LABORATORIES]5
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
ACTIVE INGREDIENTPACLITAXEL INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]4
ACTIVE MOIETYPACLITAXEL INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]4
ACTIVE INGREDIENTPACLITAXEL INJECTION [WG CRITICAL CARE, LLC]2
ACTIVE MOIETYPACLITAXEL INJECTION [WG CRITICAL CARE, LLC]2
ACTIVE INGREDIENTPACLITAXEL INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYPACLITAXEL INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYPACLITAXEL INJECTION [ONCO THERAPIES LIMITED ]1
ACTIVE INGREDIENTPACLITAXEL INJECTION [ONCO THERAPIES LIMITED ]1
ACTIVE INGREDIENTPACLITAXEL INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYPACLITAXEL INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1